Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research

NCT07403071

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study

NCT07398638

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects

NCT07400744

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma

NCT07234721

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Trial of Baricitinib in Patients With Cardiac Sarcoidosis

NCT06868381

Conditions: Cardiac Sarcoidosis, Hemic and Lymphatic Diseases, Hypersensitivity, +5 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Not yet recruiting

A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma（LB2505-0001）

NCT07399444

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

View Trial Details

Not yet recruiting

Exercise Therapy for Multiple Myeloma Patients

NCT07388147

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Heidelberg University Hospital - GMMG Study Group Heidelberg, Germany

View Trial Details

Not yet recruiting

CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma

NCT07383233

Conditions: Acute Leukemia, CAR T Cell Therapy, Hemic and Lymphatic Diseases, +7 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment

NCT07376720

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not yet recruiting

Effects of Controlled Breathing on Cardiorespiratory Variables in Multiple Myeloma

NCT07376733

Conditions: Blood Protein Disorders, Breathing Exercises, Breathing Techniques, +27 more
Locations: Not specified

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions